Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

676 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Strategies to promote translational research within the European Organisation for Research and Treatment of Cancer (EORTC) Head and Neck Cancer Group: a report from the Translational Research Subcommittee.
Psyrri A, Licitra L, Lacombe D, Schuuring E, Budach W, Ozsahin M, Knecht R, Vermorken JB, Langendijk JA. Psyrri A, et al. Among authors: lacombe d. Ann Oncol. 2010 Oct;21(10):1952-1960. doi: 10.1093/annonc/mdq060. Epub 2010 Mar 19. Ann Oncol. 2010. PMID: 20305037 Free PMC article. Review.
Development of clinical trial protocols involving advanced radiation therapy techniques: the European Organisation for Research and Treatment of Cancer Radiation Oncology Group approach.
Fairchild A, Bar-Deroma R, Collette L, Haustermans K, Hurkmans C, Lacombe D, Maingon P, Poortmans P, Tomsej M, Weber DC, Gregoire V. Fairchild A, et al. Among authors: lacombe d. Eur J Cancer. 2012 May;48(7):1048-54. doi: 10.1016/j.ejca.2012.02.008. Epub 2012 Mar 1. Eur J Cancer. 2012. PMID: 22387181
New validated prognostic models and prognostic calculators in patients with low-grade gliomas diagnosed by central pathology review: a pooled analysis of EORTC/RTOG/NCCTG phase III clinical trials.
Gorlia T, Wu W, Wang M, Baumert BG, Mehta M, Buckner JC, Shaw E, Brown P, Stupp R, Galanis E, Lacombe D, van den Bent MJ. Gorlia T, et al. Among authors: lacombe d. Neuro Oncol. 2013 Nov;15(11):1568-79. doi: 10.1093/neuonc/not117. Epub 2013 Sep 18. Neuro Oncol. 2013. PMID: 24049111 Free PMC article.
Towards new methods for the determination of dose limiting toxicities and the assessment of the recommended dose for further studies of molecularly targeted agents--dose-Limiting Toxicity and Toxicity Assessment Recommendation Group for Early Trials of Targeted therapies, an European Organisation for Research and Treatment of Cancer-led study.
Postel-Vinay S, Collette L, Paoletti X, Rizzo E, Massard C, Olmos D, Fowst C, Levy B, Mancini P, Lacombe D, Ivy P, Seymour L, Le Tourneau C, Siu LL, Kaye SB, Verweij J, Soria JC. Postel-Vinay S, et al. Among authors: lacombe d. Eur J Cancer. 2014 Aug;50(12):2040-9. doi: 10.1016/j.ejca.2014.04.031. Epub 2014 May 28. Eur J Cancer. 2014. PMID: 24880774
International Rare Cancers Initiative (IRCI).
Keat N, Law K, McConnell A, Seymour M, Welch J, Trimble T, Lacombe D, Negrouk A. Keat N, et al. Among authors: lacombe d. Ecancermedicalscience. 2013 May 21;7:ed20. doi: 10.3332/ecancer.2013.ed20. eCollection 2013. Ecancermedicalscience. 2013. PMID: 24883089 Free PMC article. No abstract available.
676 results